Engaging GPs and primary care patients in research: implications of the ASPREE trial for future studies

Affiliations

Editorial

James P Sheppard et al. Med J Aust. 2019 Mar.

. 2019 Mar;210(4):159-160.

doi: 10.5694/mja2.50023. Epub 2019 Feb 18.

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

No abstract available

Keywords: Primary care; Randomized controlled trial as topic.

Conflict of interest statement

Competing interests

No relevant disclosures.

1. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–60. doi: 10.1016/S0140-6736(09)60503-1. - DOI - PMC - PubMed
1. Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(3):209–16. - PubMed
1. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. N Engl J Med. 2018;379(16):1519–28. doi: 10.1056/NEJMoa1803955. - DOI - PMC - PubMed
1. McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018;379(16):1509–18. doi: 10.1056/NEJMoa1805819. - DOI - PMC - PubMed
1. McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of Aspirin on Disability-free Survival in the Healthy Elderly. N Engl J Med. 2018;379(16):1499–508. doi: 10.1056/NEJMoa1800722. - DOI - PMC - PubMed